NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of novel carbohydrate therapeutic compounds, today announced that David Platt, Ph.D., Chief Executive Officer of Pro-Pharmaceuticals, Inc., is scheduled to present a corporate overview and update on Thursday, November 2 at 2:30 p.m. (Eastern Time) at MASS Opportunities: A Biotechnology Investment Conference to be held at the Hilton Logan Airport Hotel in Boston, Massachusetts.
